Trial intelligence / Profile preview

COMBOS: Lovaza + Simvastatin in Hypertriglyceridemia

NCT00246701Phase 3Completed

Sponsor
GSK
Start
Nov 2005
Primary completion
Jun 2006
Modality
Small Molecules
01

Overview

A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia, sponsored by GSK. Started Nov 2005; status: completed.

02

Drugs

eicosapentaenoic acid + docosahexaenoic acid
03

Conditions

hypertriglyceridemia

Beyond the preview

Go deeper on NCT00246701.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00246701.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call